InvestorsHub Logo
Followers 46
Posts 2450
Boards Moderated 0
Alias Born 04/17/2019

Re: MaxYazger post# 69058

Friday, 04/17/2020 12:57:11 AM

Friday, April 17, 2020 12:57:11 AM

Post# of 233136
GILD would face shareholder lawsuits and have the Board of Directors and CEO thrown out if they made an appropriate offer.

A quick glance shows that Arcus has anti-PD-1 drugs. Gilead could go head to head with Keytruda. Meanwhile lowering PD-1 is just one of the ways leronlimab fights cancer.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News